Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates
Author(s) -
Helisane Lima,
Juliana Maia,
Francisco Bandeira
Publication year - 2014
Publication title -
clinical medicine insights endocrinology and diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 15
ISSN - 1179-5514
DOI - 10.4137/cmed.s15086
Subject(s) - strontium ranelate , bone mineral , osteocalcin , bone remodeling , medicine , osteoporosis , femoral neck , endocrinology , n terminal telopeptide , urology , bone density , chemistry , alkaline phosphatase , biochemistry , enzyme
To evaluate the responses of C-terminal telopeptide (CTX) and serum osteocalcin after the first 4 months of treatment with strontium ranelate (SR) and demonstrate their association with long-term bone density changes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom